C
Christopher J. O’Donnell
Researcher at Pfizer
Publications - 113
Citations - 3744
Christopher J. O’Donnell is an academic researcher from Pfizer. The author has contributed to research in topics: Antibody-drug conjugate & Cancer. The author has an hindex of 32, co-authored 113 publications receiving 3215 citations. Previous affiliations of Christopher J. O’Donnell include University of California, Irvine & University of Wisconsin-Madison.
Papers
More filters
Journal ArticleDOI
Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
Pavel Strop,Shu-Hui Liu,Magdalena Dorywalska,Kathy Delaria,Russell Dushin,Thomas-Toan Tran,Wei-Hsien Ho,Santiago E. Farias,Meritxell Galindo Casas,Yasmina Noubia Abdiche,Dahui Zhou,Ramalakshmi Yegna Chandrasekaran,Caroline Samain,Carole M. Loo,Andrea Rossi,Mathias Rickert,Stellanie Krimm,Teresa Wong,Sherman Michael Chin,Jessica Yu,Jeanette Dilley,Javier Chaparro-Riggers,Filzen Gary Frederick,Christopher J. O’Donnell,Fang Wang,Jeremy S. Myers,Jaume Pons,David L. Shelton,Arvind Rajpal +28 more
TL;DR: It is shown that the conjugation site has significant impact on ADC stability and pharmacokinetics in a species-dependent manner and can be directly attributed to the position of the linkage rather than the chemical instability, as was observed with a maleimide linkage.
Journal ArticleDOI
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
Antonia F. Stepan,Chakrapani Subramanyam,Ivan Viktorovich Efremov,Jason K. Dutra,Theresa J. O’Sullivan,Kenneth J. DiRico,W. Scott McDonald,Annie Won,Dorff Peter H,Charles E. Nolan,Stacey L. Becker,Leslie R. Pustilnik,David Riddell,Gregory W. Kauffman,Bethany L. Kormos,Liming Zhang,Yasong Lu,Steven Capetta,Michael Eric Green,Karki Kapil Kumar,Evelyn Sibley,Kevin Atchison,Andrew J. Hallgren,Christine E. Oborski,Ashley Robshaw,Blossom Sneed,Christopher J. O’Donnell +26 more
TL;DR: This work presents a compelling case for its broader application as a phenyl group replacement in scenarios where the aromatic ring count impacts physicochemical parameters and overall drug-likeness.
Journal ArticleDOI
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments
Frank Loganzo,Xingzhi Tan,Matthew Sung,Guixian Jin,Jeremy S. Myers,Eugene Melamud,Fang Wang,Veronica Diesl,Maximillian T. Follettie,Sylvia Musto,My-Hanh Lam,William T. Hu,Manoj Charati,Kiran Khandke,Kenny Sung Kyoo Kim,Mike Cinque,Judy Lucas,Edmund I. Graziani,Andreas Maderna,Christopher J. O’Donnell,Kim Arndt,Hans-Peter Gerber +21 more
TL;DR: In this article, a trastuzumab-maytansinoid ADC (TM-ADC) was applied to breast cancer cell lines, and the authors found that the ADC-resistant cells, 361-TM and JIMT1-TM, were characterized by cytotoxicity, proteomic, transcriptional and other profiling.
Journal ArticleDOI
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
Magdalena Dorywalska,Russell Dushin,Ludivine Moine,Santiago E. Farias,Dahui Zhou,Thayalan Navaratnam,Victor Lui,Adela Hasa-Moreno,Meritxell Galindo Casas,Thomas-Toan Tran,Kathy Delaria,Shu-Hui Liu,Davide Foletti,Christopher J. O’Donnell,Jaume Pons,David L. Shelton,Arvind Rajpal,Pavel Strop +17 more
TL;DR: Cboxylesterase 1C is identified as the enzyme responsible for the extracellular hydrolysis of valine-citrulline-p-aminocarbamate (VC-PABC)-based linkers in mouse plasma and modulated by small chemical modifications to the linker shows the opportunity to modulate the extacellular stability of cleavable ADCs without diminishing the intracellular payload release required for ADC efficacy.
Journal ArticleDOI
Kinetically guided radical-based synthesis of C(sp3)−C(sp3) linkages on DNA
Jie Wang,Helena Lundberg,Shota Asai,Pedro Martín-Acosta,Jason S. Chen,Stephen P. Brown,William Farrell,Russell Dushin,Christopher J. O’Donnell,Anokha S. Ratnayake,Paul G. Richardson,Zhiqing Liu,Tian Qin,Donna G. Blackmond,Phil S. Baran +14 more
TL;DR: A systematic approach to translating standard organic reactions to a DEL setting through the tactical combination of kinetic analysis and empirical screening with information captured from data mining is described.